HLA-E and neoplasm: In fact, masking with the monoclonal Ab (mAb) NKG2A/CD94 complex on Vδ2 T cells or MHC class I molecules on target cells increases the cytotoxic response of Vδ2 T cells to HLA-E-expressing tumor cells.